GENERALIZED GIANT-CELL TUMOR OF BONE - SUCCESSFUL TREATMENT OF PULMONARY METASTASES WITH INTERFERON-ALPHA, A CASE-REPORT

被引：31

作者：

KAISER, U ^{[1
]}

NEUMANN, K ^{[1
]}

HAVEMANN, K ^{[1
]}

机构：

[1] UNIV MARBURG,ZENTRUM PATHOL,W-3550 MARBURG,GERMANY

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1993年 / 119卷 / 05期

关键词：

GIANT CELL TUMOR; INTERFERON-ALPHA;

D O I：

10.1007/BF01212729

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report on a 37-year-old female patient with generalised giant-cell tumour of the bone, whose tumour was refractory to conventional chemotherapy. Subsequent treatment with interferon alpha2a in increasing dosage from 4x10(6) IU (three times a week) to 9x10(6) IU (three times a week) led to a significant decrease of pulmonary metastases and a stabilisation of the disease after 12 months of treatment. In progressive chemotherapy refractory giant-cell tumour interferon alpha2a may be of therapeutic benefit.

引用

页码：301 / 303

页数：3

共 7 条

[1] INTERFERONS AND BONE - A COMPARISON OF THE EFFECTS OF INTERFERON-ALPHA AND INTERFERON-GAMMA IN CULTURES OF HUMAN BONE-DERIVED CELLS AND AN OSTEOSARCOMA CELL-LINE [J].

BERESFORD, JN ;

TAYLOR, GT ;

TRIFFITT, JT .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 193 (02) :589-597

[2]

BERTONI F, 1988, CLIN ORTHOP RELAT R, V237, P275

[3]

KOMIYA S, 1990, CLIN ORTHOP RELAT R, V258, P304

[4] DOES SUCCESSFUL INTERFERON TREATMENT OF TUMOR PATIENTS REQUIRE LIFELONG TREATMENT [J].

STRANDER, H ;

BOETHIUS, J ;

ERHARDT, K ;

HAGLUND, S ;

HINDMARSH, T ;

JOHANSSON, B ;

NILSONNE, U ;

SZAMOSI, A .

JOURNAL OF INTERFERON RESEARCH, 1987, 7 (05) :619-626

[5]

STRANDER H, 1988, CLIN ASPECTS INTERFE, P165

[6]

TISCHLER HJ, 1989, BLUT, V59, P322

[7] GIANT-CELL TUMOR OF BONE - ENZYME HISTOCHEMICAL, BIOCHEMICAL AND TISSUE-CULTURE STUDIES [J].

YOSHIDA, H ;

AKEHO, M ;

YUMOTO, T .

VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1982, 395 (03) :319-330

← 1 →